Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results

Go back to Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results
POWERSHARES GLOBAL CLEAN ENERGY PORTFOLIO (NYSE: PBD) Delayed: 17.56 -0.12 (0.68%)
Previous Close $17.68    52 Week High $11.63 
Open $17.59    52 Week Low $9.19 
Day High $17.60    P/E N/A 
Day Low $17.51    EPS $0.00 
Volume 24,191       

POWERSHARES GLOBAL CLEAN ENERGY PORTFOLIO (NYSE: PBD) Delayed: 17.56 -0.12 (0.68%)
Previous Close $17.68    52 Week High $11.63 
Open $17.59    52 Week Low $9.19 
Day High $17.60    P/E N/A 
Day Low $17.51    EPS $0.00 
Volume 24,191       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.58 +0.01 (0.39%)
Previous Close $2.57    52 Week High $1.11 
Open $2.61    52 Week Low $0.41 
Day High $2.67    P/E N/A 
Day Low $2.57    EPS $-0.29 
Volume 307,312       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.58 +0.01 (0.39%)
Previous Close $2.57    52 Week High $1.11 
Open $2.61    52 Week Low $0.41 
Day High $2.67    P/E N/A 
Day Low $2.57    EPS $-0.29 
Volume 307,312